Literature DB >> 16918477

Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.

Kirsty S Nicolson1, David C Wraith.   

Abstract

Recent advances in immunology have greatly increased our understanding of immunological tolerance. In particular, there has been a resurgence of interest in mechanisms of immune regulation. Immune regulation refers to the phenomenon, previously known as immune suppression, by which excessive responses to infectious agents and hypersensitivities to otherwise innocuous antigens such as self antigens and allergens are avoided. We now appreciate that various distinct cell types mediate immune suppression and that some of these may be induced by appropriate administration of antigens, synthetic peptides and drugs of various types. The induction of antigen specific immunotherapy for treatment of autoimmune and allergic diseases remains the 'holy grail' for treatment of these diseases. This goal comes ever closer as understanding of the mechanisms of immune suppression and in particular antigen specific immunotherapy increases. Here we review evidence that immune suppression is mediated by various different subsets of CD4 T cells.

Entities:  

Mesh:

Year:  2006        PMID: 16918477      PMCID: PMC2629541          DOI: 10.2174/187152806778256098

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  77 in total

1.  A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation.

Authors:  Arnaud Foussat; Françoise Cottrez; Valérie Brun; Nathalie Fournier; Jean-Philippe Breittmayer; Hervé Groux
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 2.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

3.  Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.

Authors:  Marie-Alexandra Alyanakian; Sylvaine You; Diane Damotte; Christine Gouarin; Anne Esling; Corinne Garcia; Séverine Havouis; Lucienne Chatenoud; Jean-François Bach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

4.  Neuropilin-1: a surface marker of regulatory T cells.

Authors:  Dunja Bruder; Michael Probst-Kepper; Astrid M Westendorf; Robert Geffers; Stefan Beissert; Karin Loser; Harald von Boehmer; Jan Buer; Wiebke Hansen
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

5.  CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4.

Authors:  Haiying Liu; Bin Hu; Damo Xu; Foo Y Liew
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

6.  TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.

Authors:  Kazuhiko Nakamura; Atsushi Kitani; Ivan Fuss; Aasta Pedersen; Naohiko Harada; Hajime Nawata; Warren Strober
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

7.  Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis.

Authors:  Berent J Prakken; Rodrigo Samodal; Tho D Le; Francesca Giannoni; Gisella Puga Yung; John Scavulli; Diane Amox; Sarah Roord; Isme de Kleer; Dustan Bonnin; Paola Lanza; Charles Berry; Margherita Massa; Rosario Billetta; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

Authors:  Eleanor M Ling; Trevor Smith; X Dao Nguyen; Carol Pridgeon; Margaret Dallman; Justine Arbery; Victoria A Carr; Douglas S Robinson
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  2 in total

1.  Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Authors:  Conrad Russell Cruz; Patrick J Hanley; Hao Liu; Vicky Torrano; Yu-Feng Lin; James A Arce; Stephen Gottschalk; Barbara Savoldo; Gianpietro Dotti; Chrystal U Louis; Ann M Leen; Adrian P Gee; Cliona M Rooney; Malcolm K Brenner; Catherine M Bollard; Helen E Heslop
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

2.  Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.

Authors:  John Reynolds; Danielle S Abbott; Julieta Karegli; David J Evans; Charles D Pusey
Journal:  Am J Pathol       Date:  2009-04-30       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.